Yan Chang (言昌)言昌

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

孕三烯酮是一种在国家药监局注册认定的药品。该药品含有孕三烯酮-a41b23f0等成分。

该药品关联的活性成分包括:孕三烯酮Yunsan Xitong。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:华润紫竹药业有限公司Chinese legal name: 华润紫竹药业有限公司。

您可以探索含有相同成分的其他药品:孕三烯酮-a41b23f0成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 言昌) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 孕三烯酮Yunsan Xitong.

Manufacturers recorded for this product: 华润紫竹药业有限公司Chinese legal name: 华润紫竹药业有限公司.

Explore other medicines containing the same ingredient: 孕三烯酮 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 言昌Recorded Chinese name: 言昌
  • 剂型Dosage form: 胶囊剂Capsules
  • 规格Specification: 2.5mg/粒2.5 mg/capsule

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 华润紫竹药业有限公司Chinese legal name: 华润紫竹药业有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H19980020

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H19980020

Manufacturer

Chinese legal name: 华润紫竹药业有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H19980020

生产企业

华润紫竹药业有限公司(国产)

适应症

用于子宫内膜异位症。也用作探亲避孕或事后避孕药;对于早期妊娠,如与前列腺素合用,可提高引产成功率。

用法用量

口服:|1.用于子宫内膜异位症,一般为每次2.5mg,每周2次,第1次于月经第1天服用,3天后服用第2次,以后每周相同时间服用;|2.探亲避孕,探亲当天服3mg,以后每次房事时服1.5mg;|3.事后避孕,从月经第5~7天开始服药,每周2次(间隔3~4天),每次2.5mg;如每个周期服药8次以上,则避孕成功率高;|4.抗早孕,每日9mg(分2~3次服),连服4天,停药后2天于阴道后穹隆处放置卡前列酸(15-甲基前列腺素2α)薄膜,每次2mg每2.5小时1次,共4次,经2.5小时后肌内注射1.5~2mg卡前列酸,为一疗程,如无组织物排出,隔1天后重复疗程。

不良反应

少数人有头晕、乏力、胃部不适、痤疮、多毛及脂溢性皮炎、腿肿、体重增加、乳房缩小松弛等;也有月经周期缩短或延长、闭经、经量减少、不规则出血,但一般会自行减少。突破性出血发生率约5%。国内临床观察见有氨基转移酶升高。

禁忌

1.已知的对孕三烯酮和本品中任何成分过敏者。|2.妊娠妇女|3.哺乳期妇女|4.严重心、肾或肝功能不全|5.在既往的雌激素及/或孕激素治疗期间曾有代谢性疾病及/或血栓性静脉炎病史者。

注意事项

1.开始治疗前必须除外妊娠的可能,特别是以前有闭经的病人。某些妇女使用推荐剂量的孕三烯酮可能会抑制排卵,但是,在此治疗期间也会发生妊娠,所以,一定不可以孕三烯酮作为避孕措施。由于口服避孕药会影响孕三烯酮的作用,所以,在整个治疗期间必须使用屏障避孕法,因为孕三烯酮禁止应用于妊娠病人。|2.因为孕三烯酮偶尔会导致某些程度的体液储留,所以,对心脏或肾脏功能不全的病人应密切监视。|3.对高脂血症的病人需要监测ALAT、ASAT和胆固醇,糖尿病病人监测血糖。|4.孕三烯酮可以降低甲状腺结合球蛋白的浓度,这样会导致血浆甲状腺素总水平的降低。此点无临床意义,因为此时甲状腺素的水平同促甲状腺素的水平一样是在正常的范围之内。

贮藏

避光,密闭保存。

规格

2.5mg/粒

证据Evidence

  • 批准文号: 国药准字H19980020
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.